Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 298

Results For "SPE"

5010 News Found

Ayush Ministry signs MoU with Ministry of Rural Development to empower the rural youth
News | March 17, 2023

Ayush Ministry signs MoU with Ministry of Rural Development to empower the rural youth

The collaboration between both the ministries will play an important role in enhancing the skill and service sector related to Ayurveda


Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries
Healthcare | March 16, 2023

Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries

Expands robotics to 20+ specialities


2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
Policy | March 16, 2023

2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh

MoES have identified a potent Anti-cancer molecule named GS/IICT5/6


Biocorp and HRA Pharma to jointly develop a medical device innovation
Medical Device | March 16, 2023

Biocorp and HRA Pharma to jointly develop a medical device innovation

Biocorp will receive an initial milestone payment this year


PCI Pharma plans Biologics assembly facility in the Midwest
Packaging | March 16, 2023

PCI Pharma plans Biologics assembly facility in the Midwest

New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies


Cepheid launches its first manufacturing unit in India
News | March 15, 2023

Cepheid launches its first manufacturing unit in India

The facility has been set up to manufacture tuberculosis testing cartridges


Philips and Gibraltar Health Authority announce 16-year strategic partnership
News | March 15, 2023

Philips and Gibraltar Health Authority announce 16-year strategic partnership

Patients will no longer need to travel abroad for treatment of acute cardiac diseases


LifeSigns raises Pre-Series A
News | March 15, 2023

LifeSigns raises Pre-Series A

A funding to expand operations and provide better patient care


Pfizer acquires Seagen for US$ 43 billion to battle cancer
News | March 14, 2023

Pfizer acquires Seagen for US$ 43 billion to battle cancer

Proposed combination enhances Pfizer’s position as a leading company in oncology


Briefs: Lupin and Alembic
News | March 14, 2023

Briefs: Lupin and Alembic

Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.